Dipasquale, S, Pariante, CM, Dazzan, P, Aguglia, E, McGuire, P, Mondelli, V. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res
2013; 47: 197–207.
Jerome, GJ, Young, DR, Dalcin, A, Charleston, J, Anthony, C, Hayes, J, et al Physical activity levels of persons with mental illness attending psychiatric rehabilitation programs. Schizophr Res
2009; 108: 252–7.
Cooper, J, Mancuso, SG, Borland, R, Slade, T, Galletly, C, Castle, D. Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. Aust NZ J Psychiatry
2012; 46: 851–63.
Bahorik, AL, Newhill, CE, Queen, CC, Eack, SM. Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors. Psychol Med
2014; 44: 61–9.
Treuer, T, Hoffmann, VP, Chen, AK, Irimia, V, Ocampo, M, Wang, G, et al Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study. World J Biol Psychiatry
2009; 10: 729–40.
Blouin, M, Tremblay, A, Jalbert, ME, Venables, H, Bouchard, RH, Roy, MA, et al Adiposity and eating behaviors in patients under second generation antipsychotics. Obesity
2008; 16: 1780–7.
Yum, SY, Caracci, G, Hwang, MY. Schizophrenia and eating disorders. Psychiat Clin N Am
2009; 32: 809–19.
Bonfioli, E, Berti, L, Goss, C, Muraro, F, Burti, L. Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials. BMC Psychiatry
2012; 12: 78.
Curtis, J, Watkins, A, Rosenbaum, S, Teasdale, S, Kalucy, M, Samaras, K, et al Evaluating an individualized lifestyle and lifeskills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis. Early Interv Psychiatry
2016; 10: 267–76.
Teasdale, S, Harris, S, Rosenbaum, S, Watkins, A, Samaras, K, Curtis, J, et al Individual dietetic consultations in first episode psychosis: a novel intervention to reduce cardiometabolic risk. Community Ment Health J
2014; 11: 211–4.
Shiers, D, Curtis, J. Cardiometabolic health in young people with psychosis. Lancet Psychiatry
2014; 1: 492–4.
Rosenbaum, S, Tiedemann, A, Sherrington, C, Curtis, J, Ward, PB. Physical activity interventions for people with mental illness: a systematic review and meta-analysis. J Clin Psychiatry
2014; 75: 964–74.
Alvarez-Jimenez, M, Gonzalez-Blanch, C, Crespo-Facorro, B, Hetrick, S, Rodriguez-Sanchez, JM, Perez-Iglesias, R, et al Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders. CNS Drugs
2008; 22: 547–62.
Correll, CU, Manu, P, Olshanskiy, V, Napolitano, B, Kane, JM, Malhotra, AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA
2009; 302: 1765–73.
Miller, BJ, Paschall, CB, Svendsen, DP. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv
2006; 57: 1482–7.
Newcomer, JW. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry
2006; 68: 8–13.
Hennekens, CH, Hennekens, AR, Hollar, D, Casey, DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J
2005; 150: 1115–21.
Vancampfort, D, Stubbs, B, Mitchell, AJ, De Hert, M, Wampers, M, Ward, PB, et al Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry
2015; 14: 339–47.
Franz, MJ, VanWormer, JJ, Crain, LL, Boucher, JL, Histon, T, Caplan, W, et al Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc
2007; 107: 1755–67.
Ajala, O, English, P, Pinkney, J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr
2013; 97: 505–16.
Yamaoka, K, Tango, T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med
2012; 10: 138.
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med
2009; 151: 264–9.
Critical Appraisal Skills Programme. CASP Randomised Controlled Trial Checklist.
Begg, CB, Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics
1994; 50: 1088–101.
Egger, M, Davey Smith, G, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ
1997; 315: 629–34.
Duval, S, Tweedie, R. Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics
2000; 56: 455–63.
Alvarez-Jimenez, M, Gonzalez-Blanch, C, Vazquez-Barquero, JL, Perez-Iglesias, R, Martinez-Garcia, O, Perez-Pardal, T, et al Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial. J Clin Psychiatry
2006; 67: 1253–60.
Attux, C, Martini, LC, Elkis, H, Tamai, S, Freirias, A, Camargo, MD, et al A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia. BMC Psychiatry
2013; 13: 60.
Brar, JS, Ganguli, R, Pandina, G, Turkoz, I, Berry, S, Mahmoud, R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry
2005; 66: 205–12.
Brown, C, Goetz, J, Hamera, E. Weight loss intervention for people with serious mental illness: a randomized controlled trial of the RENEW program. Psychiatr Serv
2011; 62: 800–2.
Brown, S, Chan, K. A randomized controlled trial of a brief health promotion intervention in a population with serious mental illness. J Ment Health
2006; 15: 543–9.
Brown, S, Smith, E. Can a brief health promotion intervention delivered by mental health key workers improve clients' physical health: a randomized controlled trial. J Ment Health
2009; 18: 372–8.
Cordes, J, Thunker, J, Regenbrecht, G, Zielasek, J, Correll, CU, Schmidt-Kraepelin, C, et al Can an early weight management program (WMP) prevent olanzapine (OLZ) induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four-and 48-week results from a 6-month randomized trial. World J Biol Psychiatry
2014; 15: 229–41.
Daumit, GL, Dickerson, FB, Wang, NY, Dalcin, A, Jerome, GJ, Anderson, CAM, et al A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med
2013; 368: 1594–602.
Evans, S, Newton, R, Higgins, S. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust NZ J Psychiatry
2005; 39: 479–86.
Forsberg, KA, Bjorkman, T, Sandman, PO, Sandlund, M. Influence of a lifestyle intervention among persons with a psychiatric disability: a cluster randomised controlled trial on symptoms, quality of life and sense of coherence. J Clin Nurs
2010; 19: 1519–28.
Gillhoff, K, Gaab, J, Emini, L, Maroni, C, Tholuck, J, Greil, L. Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial. Prim Care Companion J Clin Psychiatry
Goldberg, RW, Reeves, G, Tapscott, S, Medoff, D, Dickerson, F, Goldberg, AP, et al ‘MOVE!’: Outcomes of a weight loss program modified for veterans with serious mental illness. Psychiatr Serv
2013; 64: 737–44.
Hjorth, P, Davidsen, AS, Kilian, R, Pilgaard Eriksen, S, Jensen, SO, Sorensen, HO, et al Improving the physical health of long-term psychiatric inpatients. Aust NZ J Psychiatry
2014; 48: 861–70.
Iglesias-Garcia, C, Toimil-Iglesias, A, Alonso-Villa, MJ. Pilot study of the efficacy of an educational programme to reduce weight, on overweight and obese patients with chronic stable schizophrenia. J Psychiatr Ment Health Nurs
2010; 17: 849–51.
Jean-Baptiste, M, Tek, C, Liskov, E, Chakunta, UR, Nicholls, S, Hassan, AQ, et al A pilot study of a weight management program with food provision in schizophrenia. Schizophr Res
2007; 96: 198–205.
Kwon, JS, Choi, JS, Bahk, WM, Yoon Kim, C, Hyung Kim, C, Chul Shin, Y, et al Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: a 12-week randomized controlled clinical trial. J Clin Psychiatry
2006; 67: 547–53.
Littrell, KH, Hilligoss, NM, Kirshner, CD, Petty, RG, Johnson, CG. The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh
2003; 35: 237–41.
Lovell, K, Wearden, A, Bradshaw, T, Tomenson, B, Pedley, R, Davies, LM, et al An exploratory randomized controlled study of a healthy living intervention in early intervention services for psychosis: the INTERvention to encourage ACTivity, improve diet, and reduce weight gain (INTERACT) study. J Clin Psychiatry
2014; 75: 498–505.
Mauri, M, Simoncini, M, Castrogiovanni, S, Iovieno, N, Cecconi, D, Dell'Agnello, G, et al A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacopsychiatry
2008; 41: 17–23.
McCreadie, RG, Kelly, C, Connolly, M, Williams, S, Baxter, G, Lean, M, et al Dietary improvement in people with schizophrenia: randomised controlled trial. Br J Psychiatry
2005; 187: 346–51.
McKibbin, CL, Patterson, TL, Norman, G, Patrick, K, Jin, H, Roesch, S, et al A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res
2006; 86: 36–44.
Milano, W, Grillo, F, Del Mastro, A, De Rosa, M, Sanseverino, B, Petrella, C, et al Appropriate intervention strategies for weight gain induced by olanzapine: a randomized controlled study. Adv Ther
2007; 24: 123–34.
Scocco, P, Longo, R, Caon, F. Weight change in treatment with olanzapine and a psychoeducational approach. Eat Behav
2006; 7: 115–24.
Usher, K, Park, T, Foster, K, Buettner, P. A randomized controlled trial undertaken to test a nurse-led weight management and exercise intervention designed for people with serious mental illness who take second generation antipsychotics. J Adv Nurs
2013; 69: 1539–48.
Weber, M, Wyne, K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res
2006; 83: 95–101.
Wu, MK, Wang, CK, Bai, YM, Huang, CY, Lee, SD. Outcomes of obese, clozapinetreated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv
2007. 58: 544–50.
Alvarez-Jimenez, M, Martinez-Garcia, O, Perez-Iglesias, R, Ramirez, ML, Vazquez-Barquero, JL, Crespo-Facorro, B. Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Schizophr Res
2010; 116: 16–9.
McKibbin, CL, Golshan, S, Griver, K, Kitchen, K, Wykes, TL. A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysis. Schizophr Res
2010; 121: 203–6.
Walker, ER, McGee, RE, Druss, BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry
2015; 72: 334–41.
Alvarez-Jimenez, M, Hetrick, SE, Gonzalez-Blanch, C, Gleeson, JF, McGorry, PD. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry
2008; 193: 101–7.
Bruins, J, Jorg, F, Bruggeman, R, Slooff, C, Corpeleijn, E, Pijnenborg, M. The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis. PloS One
2014; 9: e112276.
Higgins, JPT, Green, S. Multiplicity in systematic reviews. In Cochrane Handbook for Systematic Reviews of Interventions: 16.
Cochrane Collaboration, 2011.
Huang, J, Frohlich, J, Ignaszewski, AP. The impact of dietary changes and dietary supplements on lipid profile. Can J Cardiol
2011; 27: 488–505.
Panoulas, VF, Ahmad, N, Fazal, AA, Kassamall, RH, Nightingale, P, Gitas, GD, et al The inter-operator variability in measuring waist circumference and its potential impact on the diagnosis of the metabolic syndrome. Postgrad Med J
2008; 84: 344–7.